Shared parameter model for competing risks and different data summaries in meta‐analysis: Implications for common and rare outcomes
暂无分享,去创建一个
[1] J. Mann,et al. Benefits from antidepressants: synthesis of 6-week patient-level outcomes from double-blind placebo-controlled randomized trials of fluoxetine and venlafaxine. , 2012, Archives of general psychiatry.
[2] Peter Cummings,et al. The relative merits of risk ratios and odds ratios. , 2009, Archives of pediatrics & adolescent medicine.
[3] Nicky J Welton,et al. Network meta-analysis with competing risk outcomes. , 2010, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
[4] David J. Lunn,et al. The BUGS Book: A Practical Introduction to Bayesian Analysis , 2013 .
[5] Wim Van den Noortgate,et al. Assessing meta‐regression methods for examining moderator relationships with dependent effect sizes: A Monte Carlo simulation , 2017, Research synthesis methods.
[6] Kerrie Mengersen,et al. Multivariate meta‐analysis , 2003, Statistics in medicine.
[7] Guido Schwarzer,et al. Meta‐analysis for aggregated survival data with competing risks: a parametric approach using cumulative incidence functions , 2016, Research synthesis methods.
[8] Ludwig Kappos,et al. Oral fingolimod or intramuscular interferon for relapsing multiple sclerosis. , 2010, The New England journal of medicine.
[9] Nicky J Welton,et al. Evidence Synthesis for Decision Making in Healthcare , 2012 .
[10] J. T. Wulu,et al. Regression analysis of count data , 2002 .
[11] Nicky J Welton,et al. A Generalised Linear Modelling Framework for Pairwise and Network Meta-Analysis of Randomised Controlled Trials , 2014 .
[12] M. Pirmohamed,et al. Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients , 2004, BMJ : British Medical Journal.
[13] Alex J. Sutton,et al. Multiparameter evidence synthesis in epidemiology and medical decision‐making: current approaches , 2006 .
[14] Nicky J Welton,et al. Controlling ecological bias in evidence synthesis of trials reporting on collapsed and overlapping covariate categories , 2010, Statistics in medicine.
[15] Jason P. Fine,et al. Statistical Primer for Cardiovascular Research Introduction to the Analysis of Survival Data in the Presence of Competing Risks , 2022 .
[16] Michael J Crowther,et al. Using simulation studies to evaluate statistical methods , 2017, Statistics in medicine.
[17] Nicola J Cooper,et al. Network meta-analysis of multiple outcome measures accounting for borrowing of information across outcomes , 2014, BMC Medical Research Methodology.
[18] Giovanni Parmigiani,et al. Meta-Analysis of Migraine Headache Treatments: Combining Information from Heterogeneous Designs , 1999 .
[19] A. Lazo-Langner,et al. New oral anticoagulants , 2013, Canadian Medical Association Journal.
[20] Nicky J Welton,et al. NICE DSU Technical Support Document 2: A Generalised Linear Modelling Framework for Pairwise and Network Meta-Analysis of Randomised Controlled Trials , 2011 .
[21] J. Ioannidis,et al. Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis , 2018, The Lancet.
[22] F Gueyffier,et al. Multivariate meta-analysis using individual participant data , 2014 .
[23] M. Coleman,et al. Cancer survival in Europe 1999-2007 by country and age: results of EUROCARE--5-a population-based study. , 2014, The Lancet. Oncology.
[24] R Core Team,et al. R: A language and environment for statistical computing. , 2014 .
[25] Andrew Thomas,et al. WinBUGS - A Bayesian modelling framework: Concepts, structure, and extensibility , 2000, Stat. Comput..
[26] F Mosteller,et al. Meta-analysis of multiple outcomes by regression with random effects. , 1998, Statistics in medicine.
[27] S. Dias,et al. Different Methods for Modelling Severe Hypoglycaemic Events: Implications for Effectiveness, Costs and Health Utilities , 2018, PharmacoEconomics.
[28] David C Hoaglin,et al. Conducting indirect-treatment-comparison and network-meta-analysis studies: report of the ISPOR Task Force on Indirect Treatment Comparisons Good Research Practices: part 2. , 2011, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.
[29] A E Ades,et al. A chain of evidence with mixed comparisons: models for multi‐parameter synthesis and consistency of evidence , 2003, Statistics in medicine.
[30] Neil Hawkins,et al. Network meta-analysis on the log-hazard scale, combining count and hazard ratio statistics accounting for multi-arm trials: A tutorial , 2010, BMC medical research methodology.
[31] Nicky J Welton,et al. Evidence Synthesis for Decision Making in Healthcare: Welton/Evidence Synthesis for Decision Making in Healthcare , 2012 .
[32] J. Sterne,et al. Oral anticoagulants for primary prevention, treatment and secondary prevention of venous thromboembolic disease, and for prevention of stroke in atrial fibrillation: systematic review, network meta-analysis and cost-effectiveness analysis. , 2017, Health technology assessment.
[33] Gilbert MacKenzie,et al. The Statistical Analysis of Failure Time Data , 1982 .
[34] Deborah M Caldwell,et al. Oral anticoagulants for prevention of stroke in atrial fibrillation: systematic review, network meta-analysis, and cost effectiveness analysis , 2017, BMJ.
[35] A E Ades,et al. Synthesis of survival and disease progression outcomes for health technology assessment of cancer therapies , 2010, Research Synthesis Methods.
[36] A E Ades,et al. Mixed treatment comparison with multiple outcomes reported inconsistently across trials: Evaluation of antivirals for treatment of influenza A and B , 2008, Statistics in medicine.
[37] R J Carroll,et al. On meta-analytic assessment of surrogate outcomes. , 2000, Biostatistics.
[38] J. Kalbfleisch,et al. The Statistical Analysis of Failure Time Data: Kalbfleisch/The Statistical , 2002 .
[39] Alex J. Sutton,et al. Evidence Synthesis for Decision Making 2 , 2013, Medical decision making : an international journal of the Society for Medical Decision Making.
[40] R. Hart,et al. Antithrombotic Therapy To Prevent Stroke in Patients with Atrial Fibrillation , 2000 .
[41] Ingram Olkin,et al. A method for the meta‐analysis of mutually exclusive binary outcomes , 2008, Statistics in medicine.